Abstract: The present invention relates to compounds and methods which may be useful as inhibitors of phosphodiesterase 4 (PD E4) for the treatment or prevention of inflammatory diseases and other diseases involving elevated levels of cytokines and proinflammatory mediators.
Type:
Grant
Filed:
July 6, 2007
Date of Patent:
December 20, 2011
Assignee:
Kalypsys
Inventors:
Steven P. Govek, Andrew K. Shiau, Stewart A. Noble, David J. Thomas